(VIANEWS) – BUREAU VERITAS (BVI.PA), TOTENS SPAREBANK (TOTG.OL), SARTORIUS STED BIO (DIM.PA) are the highest payout ratio stocks on this list.
We have collected information about stocks with the highest payout ratio so far. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. BUREAU VERITAS (BVI.PA)
75.45% Payout Ratio
Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Buildings & Infrastructure; Industry; Certification; and Consumer Products. The company engages in inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its clients in relation to regulatory or self-imposed standards, as well as issues compliance reports. It also provides laboratory and on-site testing services for manufacturing and process industries; inspection services for products, services, assets, and installations, as well as various services designed to control quality, verify quantity, and meet regulatory requirements; and certification services for management systems, products, and people. The company serves automotive and transportation, building and infrastructure, chemicals, commodities and agriculture, consumer products and retail, food, marine and offshore, oil and gas, and power and utilities industries, as well as financial services and public sectors. It operates in approximately 140 countries through a network of offices and laboratories. Bureau Veritas SA was founded in 1828 and is headquartered in Neuilly-sur-Seine, France.
Earnings Per Share
As for profitability, BUREAU VERITAS has a trailing twelve months EPS of €1.04.
PE Ratio
BUREAU VERITAS has a trailing twelve months price to earnings ratio of 27.19. Meaning, the purchaser of the share is investing €27.19 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.92%.
More news about BUREAU VERITAS.
2. TOTENS SPAREBANK (TOTG.OL)
65.22% Payout Ratio
Totens Sparebank provides various banking and financial products and services in Norway. The company offers savings and pension products; mortgage, car, other vehicle, business, and construction loans; small loans; leasing; overdrafts and bank guarantees; home, leisure, car and other vehicle, animal, company and employee, agriculture, business, data attack, property damage, craftsman, health, landlord, collective, personnel, travel, and occupational injury insurance; and business and credit cards. It also provides online and mobile banking services; and payment solutions. Totens Sparebank was founded in 1854 and is headquartered in Lena, Norway.
Earnings Per Share
As for profitability, TOTENS SPAREBANK has a trailing twelve months EPS of kr22.35.
PE Ratio
TOTENS SPAREBANK has a trailing twelve months price to earnings ratio of 12.21. Meaning, the purchaser of the share is investing kr12.21 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.15%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 15.2% and positive 10.2% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.2%, now sitting on 608.74M for the twelve trailing months.
Sales Growth
TOTENS SPAREBANK’s sales growth is 14.7% for the ongoing quarter and 4% for the next.
Volume
Today’s last reported volume for TOTENS SPAREBANK is 165 which is 86.26% below its average volume of 1201.
More news about TOTENS SPAREBANK.
3. SARTORIUS STED BIO (DIM.PA)
41.07% Payout Ratio
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.02%.
Sales Growth
SARTORIUS STED BIO’s sales growth is 7.9% for the ongoing quarter and 6.5% for the next.
More news about SARTORIUS STED BIO.
4. MANITOU BF (MTU.PA)
31.69% Payout Ratio
Manitou BF SA, together with its subsidiaries, engages in the development, manufacture, and provision of equipment and services worldwide. It operates in two divisions, Product, and Services and Solutions. The company offers material handling, access, and earthmoving equipment, including rough-terrain fixed, rotating, and heavy-duty telehandlers; rough-terrain, semi-industrial, and industrial forklift trucks; skid-steer, articulated, backhoe, and track loaders; aerial work platforms; and truck-mounted forklifts, as well as warehousing equipment. It also provides attachments, such as buckets, clamps, cups, fork handling solutions, forks and grapples, jibs, work platforms, skips, sweepers and cleaners, winches, mining accessories, and miscellaneous attachments, as well as backrest, carriage, and interface references. In addition, the company offers value added services comprising technical training, new or refurbished spare parts, after-sales service, machine connectivity, fleet management, financing solutions, maintenance and warranty extension contracts, rent-to-rent leases, full-service contracts, recovery, repair, and resale of used equipment. The company offers its products through a network of dealers under the Manitou, Gehl, and Mustang by Manitou brands in agriculture, construction, industry, aeronautics, defense, environment, mining and quarries, and oil and gas markets. Manitou BF SA was incorporated in 1954 and is headquartered in Ancenis, France.
Earnings Per Share
As for profitability, MANITOU BF has a trailing twelve months EPS of €3.75.
PE Ratio
MANITOU BF has a trailing twelve months price to earnings ratio of 6.76. Meaning, the purchaser of the share is investing €6.76 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.56%.
More news about MANITOU BF.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Sales Growth
1’s sales growth is 1% for the current quarter and 1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
More news about 1.
